|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 19984 |
FusionGeneSummary for LPCAT1_ENTPD7 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LPCAT1_ENTPD7 | Fusion gene ID: 19984 | Hgene | Tgene | Gene symbol | LPCAT1 | ENTPD7 | Gene ID | 79888 | 57089 |
| Gene name | lysophosphatidylcholine acyltransferase 1 | ectonucleoside triphosphate diphosphohydrolase 7 | |
| Synonyms | AGPAT10|AGPAT9|AYTL2|LPCAT-1|PFAAP3|lpcat|lysoPAFAT | LALP1 | |
| Cytomap | 5p15.33 | 10q24.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | lysophosphatidylcholine acyltransferase 11-acylglycerophosphocholine O-acyltransferase1-alkylglycerophosphocholine O-acetyltransferaseLPC acyltransferase 1acetyl-CoA:lyso-PAF acetyltransferaseacetyl-CoA:lyso-platelet-activating factor acetyltransfera | ectonucleoside triphosphate diphosphohydrolase 7NTPDase 7lysosomal apyrase-like protein 1 | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | Q8NF37 | Q9NQZ7 | |
| Ensembl transtripts involved in fusion gene | ENST00000283415, ENST00000503252, | ENST00000370489, | |
| Fusion gene scores | * DoF score | 6 X 5 X 4=120 | 2 X 2 X 1=4 |
| # samples | 7 | 2 | |
| ** MAII score | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/4*10)=2.32192809488736 | |
| Context | PubMed: LPCAT1 [Title/Abstract] AND ENTPD7 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | LPCAT1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling | 21498505 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | DB311369 | LPCAT1 | chr5 | 1461599 | + | ENTPD7 | chr10 | 101468607 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000283415 | ENST00000370489 | LPCAT1 | chr5 | 1461599 | + | ENTPD7 | chr10 | 101468607 | - |
| intron-intron | ENST00000503252 | ENST00000370489 | LPCAT1 | chr5 | 1461599 | + | ENTPD7 | chr10 | 101468607 | - |
Top |
FusionProtFeatures for LPCAT1_ENTPD7 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LPCAT1 | ENTPD7 |
| Possesses both acyltransferase and acetyltransferaseactivities (PubMed:16864775, PubMed:21498505). Activity iscalcium-independent (By similarity). Mediates the conversion of 1-acyl-sn-glycero-3-phosphocholine (LPC) into phosphatidylcholine(PC) (PubMed:21498505). Displays a clear preference for saturatedfatty acyl-CoAs, and 1-myristoyl or 1-palmitoyl LPC as acyl donorsand acceptors, respectively (PubMed:16704971). May synthesizephosphatidylcholine in pulmonary surfactant, thereby playing apivotal role in respiratory physiology (PubMed:16864775). Involvedin the regulation of lipid droplet number and size(PubMed:25491198). {ECO:0000250|UniProtKB:Q3TFD2,ECO:0000269|PubMed:16864775, ECO:0000269|PubMed:21498505,ECO:0000269|PubMed:25491198}. | Preferentially hydrolyzes nucleoside 5'-triphosphates.The order of activity with respect to possible substrates is UTP >GTP > CTP. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LPCAT1_ENTPD7 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LPCAT1_ENTPD7 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LPCAT1_ENTPD7 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LPCAT1_ENTPD7 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|